Myriam Guiral, the new SeqOne CCO EMEA & Biopharma Head

Published on 22 March 2021

We are very pleased to announce the appointment of Myriam Guiral to the role of CCO EMEA & Biopharma Head. Myriam has more than 20 years of global sales and general leadership experience that will be critical to the commercial development of SeqOne Genomics. Prior to joining SeqOne, Myriam led OncoDNA’s global commercial team and before that held leadership roles at IQVIA, GE Healthcare, Abbott Diagnostics and Becton Dickinson.

‘’I am really proud to take on a leadership commercial role at this exciting time for SeqOne Genomics as it accelerates its global expansion. The company’s genomics analysis platform is well established in France and poised for international expansion. I will also spearhead the company’s new genomic analysis solution for pharmaceutical and biotech industries.‘’ said Myriam.

Need help improving your genomic analysis process ?
We'd love to help !